Koninklijke Philips N.V. (NYSE:PHG) Shares Acquired by Cerity Partners LLC

Cerity Partners LLC boosted its stake in shares of Koninklijke Philips N.V. (NYSE:PHG - Free Report) by 30.6% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 80,767 shares of the technology company's stock after purchasing an additional 18,906 shares during the quarter. Cerity Partners LLC's holdings in Koninklijke Philips were worth $2,051,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in PHG. Bank of New York Mellon Corp boosted its position in Koninklijke Philips by 2.8% during the 4th quarter. Bank of New York Mellon Corp now owns 55,576 shares of the technology company's stock valued at $1,407,000 after purchasing an additional 1,501 shares during the period. Charles Schwab Investment Management Inc. boosted its position in Koninklijke Philips by 10.8% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 61,258 shares of the technology company's stock valued at $1,551,000 after purchasing an additional 5,968 shares during the period. Farther Finance Advisors LLC boosted its position in Koninklijke Philips by 37.1% during the 4th quarter. Farther Finance Advisors LLC now owns 2,150 shares of the technology company's stock valued at $54,000 after purchasing an additional 582 shares during the period. Avantax Advisory Services Inc. boosted its position in Koninklijke Philips by 23.7% during the 4th quarter. Avantax Advisory Services Inc. now owns 11,575 shares of the technology company's stock valued at $293,000 after purchasing an additional 2,219 shares during the period. Finally, Millstone Evans Group LLC acquired a new position in Koninklijke Philips during the 4th quarter valued at approximately $60,000. Institutional investors and hedge funds own 13.67% of the company's stock.

Koninklijke Philips Stock Performance

Shares of NYSE PHG opened at $24.58 on Monday. The company has a current ratio of 1.28, a quick ratio of 0.79 and a debt-to-equity ratio of 0.60. The stock has a 50 day simple moving average of $23.58 and a 200-day simple moving average of $24.93. The company has a market cap of $23.67 billion, a PE ratio of 57.16, a P/E/G ratio of 0.70 and a beta of 0.76. Koninklijke Philips N.V. has a 12-month low of $20.61 and a 12-month high of $31.57.

Koninklijke Philips (NYSE:PHG - Get Free Report) last issued its quarterly earnings data on Tuesday, May 6th. The technology company reported $0.27 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.14 by $0.13. The business had revenue of $4.31 billion during the quarter, compared to the consensus estimate of $4.10 billion. Koninklijke Philips had a return on equity of 10.97% and a net margin of 2.11%. The business's revenue was down 1.0% on a year-over-year basis. During the same period in the previous year, the firm posted $0.21 earnings per share. On average, equities research analysts forecast that Koninklijke Philips N.V. will post 1.63 EPS for the current year.

Wall Street Analyst Weigh In

Separately, Wall Street Zen upgraded Koninklijke Philips from a "hold" rating to a "buy" rating in a research report on Saturday, July 12th. One equities research analyst has rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Buy".

Koninklijke Philips Company Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.

Want to see what other hedge funds are holding PHG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Koninklijke Philips N.V. (NYSE:PHG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.